X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs SUN PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD SUN PHARMA ALEMBIC LTD/
SUN PHARMA
 
P/E (TTM) x 52.9 49.0 108.0% View Chart
P/BV x 2.2 4.0 55.9% View Chart
Dividend Yield % 0.5 0.6 79.4%  

Financials

 ALEMBIC LTD   SUN PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
SUN PHARMA
Mar-17
ALEMBIC LTD/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs72842 8.6%   
Low Rs34572 5.9%   
Sales per share (Unadj.) Rs4.7131.6 3.6%  
Earnings per share (Unadj.) Rs6.132.7 18.7%  
Cash flow per share (Unadj.) Rs6.238.0 16.4%  
Dividends per share (Unadj.) Rs0.203.50 5.7%  
Dividend yield (eoy) %0.40.5 76.3%  
Book value per share (Unadj.) Rs40.7152.7 26.6%  
Shares outstanding (eoy) m267.032,399.26 11.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.35.4 209.6%   
Avg P/E ratio x8.721.6 40.1%  
P/CF ratio (eoy) x8.518.6 45.5%  
Price / Book Value ratio x1.34.6 28.1%  
Dividend payout %3.310.7 30.6%   
Avg Mkt Cap Rs m14,1391,696,877 0.8%   
No. of employees `000NA17.5 0.0%   
Total wages/salary Rs m20749,023 0.4%   
Avg. sales/employee Rs ThNM18,028.3-  
Avg. wages/employee Rs ThNM2,798.8-  
Avg. net profit/employee Rs ThNM4,479.5-  
INCOME DATA
Net Sales Rs m1,255315,784 0.4%  
Other income Rs m3706,232 5.9%   
Total revenues Rs m1,625322,016 0.5%   
Gross profit Rs m111100,893 0.1%  
Depreciation Rs m3812,648 0.3%   
Interest Rs m23,998 0.0%   
Profit before tax Rs m44290,479 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,21299 1,220.5%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2412,116 0.2%   
Profit after tax Rs m1,63078,462 2.1%  
Gross profit margin %8.931.9 27.7%  
Effective tax rate %5.413.4 40.5%   
Net profit margin %129.824.8 522.6%  
BALANCE SHEET DATA
Current assets Rs m1,867329,537 0.6%   
Current liabilities Rs m591178,870 0.3%   
Net working cap to sales %101.647.7 213.0%  
Current ratio x3.21.8 171.4%  
Inventory Days Days9479 119.3%  
Debtors Days Days7483 88.3%  
Net fixed assets Rs m1,791204,766 0.9%   
Share capital Rs m5342,399 22.3%   
"Free" reserves Rs m10,324363,997 2.8%   
Net worth Rs m10,858366,397 3.0%   
Long term debt Rs m4114,361 0.3%   
Total assets Rs m11,591614,102 1.9%  
Interest coverage x260.923.6 1,104.0%   
Debt to equity ratio x00 9.7%  
Sales to assets ratio x0.10.5 21.1%   
Return on assets %14.113.4 104.8%  
Return on equity %15.021.4 70.1%  
Return on capital %15.224.8 61.2%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1944,118 0.0%   
Fx outflow Rs m26424,484 1.1%   
Net fx Rs m-24419,634 -1.2%   
CASH FLOW
From Operations Rs m23670,822 0.3%  
From Investments Rs m-224-42,216 0.5%  
From Financial Activity Rs m-27-22,854 0.1%  
Net Cashflow Rs m-156,107 -0.2%  

Share Holding

Indian Promoters % 64.0 63.7 100.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 5.1 3.9%  
FIIs % 9.7 23.0 42.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 8.3 314.5%  
Shareholders   54,701 133,026 41.1%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   BIOCON LTD  CADILA HEALTHCARE  VENUS REMEDIES  PLETHICO PHARMA  WOCKHARDT LTD.  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 207 Points Higher; Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade in the green during the closing hours of the trading session and ended the day on a positive note.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY18); Net Profit Up 64.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ALEMBIC LTD has posted a net profit of Rs 46 m (up 64.9% YoY). Sales on the other hand came in at Rs 332 m (up 0.9% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 14, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - WYETH LTD COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS